CognoTrain develops digital therapeutics for Alzheimer's and dementia patients, offering a personalized cognitive training app and AI/ML-based wearable devices for daily care. This SaaS-based ecosystem aims to provide comprehensive support for cognitive health management.
Funding
Funding not disclosed
Founders
Product
Problem
Alzheimer's and dementia patients experience progressive memory decline, impacting their ability to recognize loved ones, navigate familiar places, and manage daily tasks. Current treatment options offer limited efficacy in slowing cognitive decline, and personalized support systems are often lacking.
Solution
CognoTrain offers a digital therapeutic ecosystem designed to support individuals in the early stages of Alzheimer's and dementia. The core of the system is a personalized cognitive training application that uses patient-specific data to create interactive memory exercises and activities. The platform aims to enhance cognitive performance, slow memory decline, and improve overall quality of life by providing customized training modules and reminders. In addition to the app, CognoTrain is developing AI/ML-based wearable devices to provide continuous support and monitoring for patients in their daily lives.
Target Audience
The primary target audience includes early-stage Alzheimer's and dementia patients, their families and caregivers, as well as senior living facilities and memory care centers.
Features
- Personalized memory training games using patient photos and audio to aid recognition.
- "All About Me" interactive activities to reinforce self-identity and personal history.
- Topological location assistant to train patients on navigating their home and frequently visited locations.
- Medication reminders with visual aids to minimize drug overdose.
- Gamified exercises designed to enhance cognitive performance in an engaging manner.
- AI/ML-based wearable devices (in development) for continuous monitoring and support.